Cardiovascular risk factors in maintenance hemodialysis patients at Friendship Hospital
Main Article Content
Abstract
Cardiovascular disease is the leading cause of death in patients with end-stage renal disease undergoing hemodialysis. A cross-sectional descriptive study was conducted on 122 outpatient hemodialysis patients at the Department of Nephrology and Dialysis, Friendship Hospital from May 2024 to July 2024 to evaluate several cardiovascular risk factors. The factors investigated included age, gender, body mass index, hypertension, diabetes mellitus, dyslipidemia, smoking, level of physical activity, and calcium-phosphorus-PTH metabolic disorders according to KDIGO 2017. The average age of the patients was 68.83 ± 15.42 years old; males accounted for 67.2%. Common cardiovascular risk factors included dyslipidemia (86.1%), hypertension (81.1%), diabetes mellitus (45.1%), sedentary lifestyle (62.3%), and smoking (41%). Logistic regression analysis revealed that smoking was significantly associated with males and younger age groups, while hypertension was more prevalent in men. Blood parathyroid hormone levels correlated positively with dialysis duration. The results suggest that patients undergoing hemodialysis have a high cardiovascular risk burden and require comprehensive management and intervention.
Article Details
Keywords
Cardiovascular risk factors, hemodialysis
References
2. Zoccali C, Mallamaci F, Adamczak M, et al. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group. Cardiovasc Res. 2023; 119(11): 2017-2032. doi:10.1093/cvr/cvad106.
3. Mikami R, Mizutani K, Gohda T, et al. Malnutrition-inflammation-atherosclerosis (MIA) syndrome associates with periodontitis in end-stage renal disease patients undergoing hemodialysis: a cross-sectional study. Sci Rep. 2023; 13(1): 11805. doi:10.1038/s41598-023-38959-0.
4. Malík J, Tuka V, Mokrejš P, et al. Echocardiography in patients with chronic kidney disease. Cor Vasa. 2018; 60(3): e287-e295. doi:10.1016/j.crvasa.2018.03.006.
5. Ferro CJ, Mark PB, Kanbay M, et al. Lipid management in patients with chronic kidney disease. Nat Rev Nephrol. 2018; 14(12): 727-749. doi:10.1038/s41581-018-0072-9.
6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017; 7(1): 1-59. doi:10.1016/j.kisu.2017.04.001.
7. Nguyễn TL, Đỗ TNĐ, Phạm TTH. Tình trạng dinh dưỡng ở bệnh nhân bệnh thận mạn giai đoạn cuối điều trị lọc máu chu kỳ tại Việt Nam. Tạp chí Dinh dưỡng & Thực phẩm. 2019; 15(3): 45-52.
8. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012; 3(1): 7. doi:10.1186/2042-6410-3-7.
9. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2023.
10. Harada M, Ueda H, Miyazaki M, et al. Physical function and physical activity in hemodialysis patients with peripheral artery disease. Hemodial Int. 2023; 27(1): 74-83. doi:10.1111/hdi.13063.
11. Tsai SH, Chen YT, Hsu CY, et al. Secondary hyperparathyroidism in chronic kidney disease: a narrative review focusing on therapeutic strategy. J Clin Med. 2024; 13(5): 1238. doi:10.3390/jcm13051238.
12. Rodríguez-Ortiz ME, Rodríguez M. Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease. F1000Res. 2020;9:F1000 Faculty Rev-1077. doi:10.12688/f1000research.25637.1.
13. Matias PJ, Ferreira C, Jorge C, et al. Bone fracture risk factors in prevalent hemodialysis patients. J Bone Miner Metab. 2020; 38(2): 205-212. doi:10.1007/s00774-019-01041-2.